The medical landscape in 2026 is witnessing a transformative era where biological materials are no longer just supplementary but are foundational to surgical success. According to the latest US Market analysis, the industry is experiencing a surge in demand driven by a healthcare system that prioritizes "first-time-right" results. Surgeons are increasingly moving toward bioactive hemostats and...